Immunic, Inc. (IMUX)
NASDAQ·Healthcare·Biotechnology
$7.67
+5.29%
Mkt Cap $111.32M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$14.50
Range $2.50 – $22.00
Implied Upside
+89.2%
Consensus $14.50 vs current $7.67
NASDAQ·Healthcare·Biotechnology
$7.67
+5.29%
Mkt Cap $111.32M
No recent rating data.
Price Target (4 analysts)
$14.50
Range $2.50 – $22.00
+89.2%
Consensus $14.50 vs current $7.67